Paroxysmal nonkinesigenic dyskinesia

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Paroxysmal Nonkinesigenic Dyskinesia
Classification and external resources
Specialty Lua error in Module:Wikidata at line 446: attempt to index field 'wikibase' (a nil value).
OMIM 118800
DiseasesDB 32382
Patient UK Paroxysmal nonkinesigenic dyskinesia
[[[d:Lua error in Module:Wikidata at line 863: attempt to index field 'wikibase' (a nil value).|edit on Wikidata]]]

Paroxysmal Nonkinesigenic Dyskinesia (PNKD) is an episodic movement disorder first described by Mount and Reback in 1940 under the name "Familial paroxysmal choreoathetosis".[1] It is a rare hereditary disease that affects various muscular and nervous systems in the body, passing to roughly fifty percent of the offspring.

Genetics

It has been mapped to chromosome 2q31-36.[2]

It has been associated with PNKD.[3]

Alternate names

The condition can and has been referred to by a number of different names since it was first described, including the following:

  • Paroxysmal nonkinesigenic dyskinesia
  • PNKD
  • Paroxysmal dystonic choreoathetosis
  • PDC
  • Mount-Reback syndrome (in honor of Lester Adrian Mount and S. Reback; the two doctors that classified it)[4]
  • Nonkinesigenic choreoathetosis
  • Familial paroxysmal choreoathetosis
  • Choreoathetosis familial paroxysmal
  • FPD1
  • DYT8
  • Dystonia 8

Symptoms

The condition manifests itself as attacks lasting from a few minutes to several hours. Episodes only happen when the individual is awake, and they remain conscious throughout the attack. Symptoms are most severe in youth and lessen with age. Sufferers can have multiple attacks on a daily basis or may have periods of weeks or months between attacks. Symptoms experienced during attacks can vary and include dystonia, chorea, athetosis, ballismus, or a combination.[5]

Triggers

While not the same in all people, there are several common triggers that can precipitate an attack:[2][6]

Treatment

Most pharmacological treatments work poorly, but the best treatment is a low dosage of clonazepam, a muscle relaxant. Patients may also benefit from other benzodiazepines, phenobarbital, and other anticonvulsants such as valproic acid.[7] Affected individuals have reported garlic to be effective for softening the attacks, but no studies have been done on this.[2]

References